(Q48320138)

10 February 2018

title

PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram (English)

1 reference

10 February 2018

0 references

1 reference

5

Christer Halldin

1 reference

10 February 2018

6

Lars Farde

1 reference

10 February 2018

author name string

Johan Lundberg

1

1 reference

10 February 2018

Jacob Strøyer Christophersen

2

1 reference

10 February 2018

Kamilla Buchberg Petersen

3

1 reference

10 February 2018

Henrik Loft

4

1 reference

10 February 2018

publication date

4 January 2007

1 reference

10 February 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

10 February 2018

volume

10

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

777-785

1 reference

10 February 2018

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Serotonin in the regulation of brain microcirculation

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

https://api.crossref.org/works/10.1017%2FS1461145706007486

1 reference

7 January 2021

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Lung as reservoir for antidepressants in pharmacokinetic drug interactions

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

R-citalopram counteracts the effect of escitalopram in a rat conditioned fear stress model of anxiety

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Escitalopram versus citalopram: the surprising role of the R-enantiomer

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Human brain atlas: For high-resolution functional and anatomical mapping

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Multimodality image registration by maximization of mutual information

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

Simplified reference tissue model for PET receptor studies.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

[(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

The advantage of using positron emission tomography in drug research

1 reference

https://api.crossref.org/works/10.1017%2FS1461145706007486

7 January 2021

10.1017/S1461145706007486

Identifiers

DOI

0 references

1 reference

10 February 2018